Clincosm LogoSign in Get a demo

Neoplasm Malignant

Showing NaN - NaN of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)

Completed
Has Results
  • Neoplasm Malignant
  • Birmingham, Alabama
  • +20 more
Mar 30, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Tumor Malignant Trial in United States (Iniparib (SAR240550-BSI-201), Gemcitabine, Carboplatin)

Completed
  • Neoplasm Malignant
  • Iniparib (SAR240550-BSI-201)
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Oct 21, 2014

Tumor Malignant Trial in Belgium, United States (SAR302503 (TG101348), Placebo SAR302503, Panolosetron)

Completed
  • Neoplasm Malignant
  • SAR302503 (TG101348)
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 3, 2014